Enabling New Therapeutic Pathways by Targeting the Extracellular Matrix
Location: United States, California, Emeryville
Total raised: $55M
Founded date: 2012
Investors 2
| Date | Name | Website |
| - | Mission Bi... | missionbio... |
| - | MBC BioLab... | mbcbiolabs... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 22.05.2017 | Series B | $30M | - |
| 01.12.2015 | Series A | $25M | Lilly Vent... |
Mentions in press and media 9
| Date | Title | Description | Source |
| 29.04.2019 | Term Sheet — Monday, April 29 | GROWTH AT ALL COSTS Good morning, Term Sheet readers — I’m back! Paid Content How can you protect ... | fortune.co... |
| 29.04.2019 | Daily funding roundup - April 29th, 2019 | Duco raised $1.7M; Specright secured $8.8M; Dyndrite closed $10M; A Cloud Guru landed $33M Duco: Du... | vator.tv/n... |
| 22.05.2017 | Symic Bio Secures $30M Series B Financing | Symic Bio, a San Francisco, CA-based biopharmaceutical company developing novel matrix regulator the... | finsmes.co... |
| 01.12.2015 | Daily funding roundup - December 1, 2015 | AppDynamics raised $158M; Symic secured $25M; Deskbookers announced $1.6M funding Deskbookers, an o... | vator.tv/n... |
| 01.12.2015 | Eli Lilly’s venture arm invests in $25M round for Symic Biom... | “We’re pretty unique in our approach to this,” Horne said. “It’s equally exciting and challenging.” ... | medcitynew... |
| 01.12.2015 | Symic Secures $25M in Series A-2 Financing | Symic, a San Francisco, CA-based clinical-stage biotherapeutics company developing multiple compound... | finsmes.co... |
| 01.12.2015 | Lilly backs a $25M round for anti-inflammatory startup Symic | Symic CEO Ken Horne San Francisco's Symic raised $25 million to fund its work on a pair of anti-inf... | fiercebiot... |
| 06.01.2015 | Symic Biomedical Secures $15M in Series A | SAN FRANCISCO, CA, Symic Biomedical announced today that the company has secured $15 million in Se... | vcnewsdail... |
| - | Eli Lilly’s venture arm invests in $25M round for Symic Biom... | Bay Area startup Symic Biomedical just closed out a $25 million Series A-2 round, led by Eli Lilly’s... | medcitynew... |